MX9804143A - Derivados sinteticos de bacterioclorofila substituidos con metal, y uso de los mismos. - Google Patents

Derivados sinteticos de bacterioclorofila substituidos con metal, y uso de los mismos.

Info

Publication number
MX9804143A
MX9804143A MX9804143A MX9804143A MX9804143A MX 9804143 A MX9804143 A MX 9804143A MX 9804143 A MX9804143 A MX 9804143A MX 9804143 A MX9804143 A MX 9804143A MX 9804143 A MX9804143 A MX 9804143A
Authority
MX
Mexico
Prior art keywords
bchl
peptide
residue
hydroxy
coor1
Prior art date
Application number
MX9804143A
Other languages
English (en)
Spanish (es)
Inventor
Avigdor Scherz
Yoram Salomon
Hugo Scheer
Gerhard Hartwich
Alexander Brandis
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of MX9804143A publication Critical patent/MX9804143A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9804143A 1995-11-24 1998-05-25 Derivados sinteticos de bacterioclorofila substituidos con metal, y uso de los mismos. MX9804143A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11612695A IL116126A0 (en) 1995-11-24 1995-11-24 Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
MX9804143A true MX9804143A (es) 1998-09-30

Family

ID=11068225

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9804143A MX9804143A (es) 1995-11-24 1998-05-25 Derivados sinteticos de bacterioclorofila substituidos con metal, y uso de los mismos.

Country Status (18)

Country Link
US (1) US6333319B1 (OSRAM)
EP (1) EP0863903B1 (OSRAM)
JP (1) JP2000500763A (OSRAM)
CN (1) CN1085211C (OSRAM)
AT (1) ATE365741T1 (OSRAM)
AU (1) AU718961B2 (OSRAM)
BR (1) BR9611452A (OSRAM)
DE (1) DE69637149T2 (OSRAM)
DK (1) DK0863903T3 (OSRAM)
ES (1) ES2288757T3 (OSRAM)
HU (1) HU223379B1 (OSRAM)
IL (1) IL116126A0 (OSRAM)
MX (1) MX9804143A (OSRAM)
NO (1) NO323478B1 (OSRAM)
PL (1) PL188811B1 (OSRAM)
PT (1) PT863903E (OSRAM)
RU (1) RU2193038C2 (OSRAM)
WO (1) WO1997019081A1 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413436B1 (en) * 1999-01-27 2002-07-02 Semitool, Inc. Selective treatment of the surface of a microelectronic workpiece
CA2353554C (en) * 1998-12-09 2011-04-26 Yeda Research And Development Co. Ltd. Palladium-substituted bacteriochlorophyll derivatives and use thereof
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
US7045117B2 (en) * 1999-12-01 2006-05-16 Yeda Research And Development Co. Ltd. Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives
WO2002013820A1 (en) * 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
RU2183956C1 (ru) * 2001-03-30 2002-06-27 Общество с ограниченной ответственностью "РАДА-ФАРМА" Фотосенсибилизатор и способ его получения
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
IL148921A0 (en) * 2002-03-26 2002-09-12 Peptor Ltd Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy
AU2003230164B2 (en) 2002-05-08 2008-05-01 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
CN2595398Y (zh) 2002-09-25 2003-12-31 王健 动态加静态磁脉冲理疗仪
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
EP2322173B1 (en) * 2004-06-07 2016-08-10 Yeda Research And Development Co., Ltd. Cationic bacteriochlorophyll derivatives and uses thereof
MX2007000338A (es) 2004-06-09 2007-03-28 Quadra Logic Tech Inc Terapia fotodinamica para el tratamiento de trastornos hiperactivos de glandulas sebaceas.
AU2007282846A1 (en) * 2006-08-07 2008-02-14 Kodesh S.A Tetraarylporphine derivatives and uses thereof
JP2010502574A (ja) * 2006-08-23 2010-01-28 イエダ リサーチ アンド デベロップメント カンパニー リミテッド Rgdペプチドとポルフィリン又は(バクテリオ)クロロフィル光合成剤とのコンジュゲート及びその使用
EP2155691B1 (en) * 2007-02-23 2016-01-13 Yeda Research and Development Co. Ltd. Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
EP2244787A1 (en) * 2008-01-28 2010-11-03 Yeda Research And Development Company Ltd. Endoscopic imaging photodynamic therapy system and methods of use
KR101595138B1 (ko) 2008-02-27 2016-02-18 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 괴사종양의 광역학요법 및 영상용 알지디(박테리오)클로로필 컨쥬게이트
RU2415868C1 (ru) 2009-09-10 2011-04-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Производные гемина, обладающие антимикробной активностью, или их фармацевтически приемлемые соли, способ получения, фармкомпозиция и применение
CN102584837A (zh) * 2012-01-18 2012-07-18 河北联合大学 天然叶绿素铁铬盐及制备方法
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
AU2014229637B2 (en) 2013-03-11 2017-05-04 Tookad Ip Sarl Method for producing bacteriochlorophyll a
CN109679110B (zh) * 2018-12-25 2020-10-09 北京科技大学 一种基于菌绿素的纳米金属-有机框架光敏剂及制备方法
CN114005684B (zh) * 2021-11-05 2023-05-05 吉林大学 不饱和叶绿素的电化学聚合薄膜及其在超级电容器上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (de) 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US5591847A (en) * 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages

Also Published As

Publication number Publication date
NO982348L (no) 1998-07-23
ATE365741T1 (de) 2007-07-15
EP0863903A1 (en) 1998-09-16
PL188811B1 (pl) 2005-04-29
NO982348D0 (no) 1998-05-22
WO1997019081A1 (en) 1997-05-29
CN1085211C (zh) 2002-05-22
JP2000500763A (ja) 2000-01-25
DE69637149T2 (de) 2008-02-28
AU718961B2 (en) 2000-05-04
DK0863903T3 (da) 2007-09-24
NO323478B1 (no) 2007-05-21
HUP9903582A3 (en) 2002-02-28
US6333319B1 (en) 2001-12-25
ES2288757T3 (es) 2008-01-16
HUP9903582A2 (hu) 2000-02-28
EP0863903B1 (en) 2007-06-27
DE69637149D1 (de) 2007-08-09
RU2193038C2 (ru) 2002-11-20
PT863903E (pt) 2007-09-07
BR9611452A (pt) 1999-02-17
CN1207741A (zh) 1999-02-10
IL116126A0 (en) 1996-01-31
PL326745A1 (en) 1998-10-26
AU7585796A (en) 1997-06-11
HU223379B1 (hu) 2004-06-28

Similar Documents

Publication Publication Date Title
MX9804143A (es) Derivados sinteticos de bacterioclorofila substituidos con metal, y uso de los mismos.
RU98111943A (ru) Синтетические металл-замещенные производные бактериохлорофилла и их применение
AU2002341034B2 (en) Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
Santos-Silva et al. Towards improved therapeutic CORMs: understanding the reactivity of CORM-3 with proteins
MXPA02005455A (es) Esteres de clorofila y bacterioclorofila, su preparacion y composiciones farmaceuticas que los contienen.
Engeseth et al. Studies of thermally induced denaturation of azurin and azurin derivatives by differential scanning calorimetry: evidence for copper selectivity
AU2002341034A1 (en) Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
Rakestraw et al. Antibody-targeted photolysis: in vitro studies with Sn (IV) chlorin e6 covalently bound to monoclonal antibodies using a modified dextran carrier.
RU2005118771A (ru) Водорастворимые анионсодержащие производные бактериохлорофилла и их применение
CA2237056A1 (en) Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
NO309481B1 (no) CNC-utvidete porfyriner, preparat og farmasöytisk preparat derav, magnetisk-resonans-avbildnings-(MRI)-kontrastmiddel, samt fremgangsmåte for fremstilling
Rimington Haem biosynthesis and porphyrias: 50 years in retrospect
WO2025123539A1 (zh) 一种具有口腔菌群水平自适应调控功能的靶向纳米酶抗菌剂及其制备方法
AU5164699A (en) Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction
Thawley et al. Antagonistic effect of zinc on increased urine δ-aminolevulinic acid excretion in lead-intoxicated rats
Moore et al. Chemistry and biochemistry of the porphyrins and porphyrias
Lagarias Bile pigment-protein interactions. Coupled oxidation of cytochrome c
WO1995000140A1 (en) Gallium complexes for the treatment of free radical-induced diseases
Dobric et al. Cardioprotective efficacy of amifostine (WR-2721) in adriamycine-treated rats
Kuznetsov et al. Content of transition group metals in bottom animals near Paramushir gas hydrated source.
Clarke et al. Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer
Blyth Some studies on the formation and interconversion of iron-sulfur-nitrosyl complexes
Zeind Stem injection as a technique for the biological incorporation of radioisotopes into foods for metabolic studies
Mydlik et al. Haemoperfusion of Alfa Amanitine--In Vitro Study
WO1997018210A1 (en) Hemoregulatory compounds